Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q3 FY25 results · Oct–Dec 2024
Bajaj Healthcare reported revenue from operations of ₹122.79 crore (up 13.1% from Q3 FY24) and net profit of ₹11.72 crore for Q3 FY25 (Oct–Dec 2024), on a standalone basis.
| Item | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 122.79 | 108.57 | +13.1% | 133.09 | −7.7% |
| Other income | 2.37 | 0.80 | +197.3% | 2.61 | −9.0% |
| Total income | 125.17 | 109.37 | +14.4% | 135.70 | −7.8% |
| Profit before tax | 11.65 | 6.33 | +84.2% | 12.45 | −6.4% |
| Net profit for the period | 11.72 | (2.20) | Turned profit | 9.46 | +23.8% |
| EPS, basic (₹) | 3.65 | (0.80) | not comparable | 3.36 | +8.6% |
| Net margin (%) | 9.5 | -2.0 | 7.1 |
Standalone
- Filed with BSE
- 12 Feb 2025, 13:03 IST
- Board meeting
- 11 Feb 2025
- Period
- 01 Oct 2024 to 31 Dec 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE